Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	cilium	PJA2 PSEN1 DNAH10 CENPF SPATA18 CAMSAP3 CIBAR2 CCDC178 ALPK1 ODF2 SPAG17 TEKT5 SLC26A6 PRPH	2.50e-05	898	89	14	GO:0005929
GeneOntologyCellularComponent	C-fiber	SCN10A PRPH	1.07e-04	4	89	2	GO:0044299
GeneOntologyCellularComponent	microtubule organizing center	PJA2 PSEN1 CENPF ARHGEF7 CAMSAP3 CIBAR2 TACC2 CCDC178 ATM ALPK1 CNTLN ODF2 KIF13A	1.34e-04	919	89	13	GO:0005815
GeneOntologyCellularComponent	ciliary basal body	PJA2 CENPF CAMSAP3 CIBAR2 CCDC178 ODF2	1.86e-04	195	89	6	GO:0036064
GeneOntologyCellularComponent	centrosome	PJA2 PSEN1 CENPF ARHGEF7 CAMSAP3 TACC2 ATM ALPK1 CNTLN ODF2 KIF13A	4.21e-04	770	89	11	GO:0005813
GeneOntologyCellularComponent	ciliary transition fiber	CENPF ODF2	7.89e-04	10	89	2	GO:0097539
GeneOntologyCellularComponent	motile cilium	DNAH10 SPATA18 CAMSAP3 ODF2 SPAG17 TEKT5 SLC26A6	8.03e-04	355	89	7	GO:0031514
GeneOntologyCellularComponent	spindle	CENPF ARHGEF7 ANXA11 KLHL42 ATM ALPK1 ODF2 PARD3	8.97e-04	471	89	8	GO:0005819
GeneOntologyCellularComponent	supramolecular fiber	KRT2 KRT75 DNAH10 XIRP2 KRT77 CAMSAP3 STYXL2 ODF2 MYZAP SPAG17 KIF13A TEKT5 PRPH	1.41e-03	1179	89	13	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	KRT2 KRT75 DNAH10 XIRP2 KRT77 CAMSAP3 STYXL2 ODF2 MYZAP SPAG17 KIF13A TEKT5 PRPH	1.50e-03	1187	89	13	GO:0099081
Domain	EPHD	KMT2C KDM4C BRD1	1.41e-04	22	87	3	PS51805
Domain	Keratin_2_head	KRT2 KRT75 KRT77	1.84e-04	24	87	3	IPR032444
Domain	Keratin_2_head	KRT2 KRT75 KRT77	1.84e-04	24	87	3	PF16208
Domain	Intermediate_filament_CS	KRT2 KRT75 KRT77 PRPH	2.12e-04	63	87	4	IPR018039
Domain	Keratin_II	KRT2 KRT75 KRT77	2.35e-04	26	87	3	IPR003054
Domain	Filament	KRT2 KRT75 KRT77 PRPH	3.36e-04	71	87	4	SM01391
Domain	IF	KRT2 KRT75 KRT77 PRPH	3.55e-04	72	87	4	PS00226
Domain	Filament	KRT2 KRT75 KRT77 PRPH	3.74e-04	73	87	4	PF00038
Domain	IF	KRT2 KRT75 KRT77 PRPH	4.36e-04	76	87	4	IPR001664
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 CENPF ANXA11 CGN TJP2 ZFR CHD2 ATM HUWE1 FSCN1 HECTD1 PRRC2B	1.25e-07	653	90	12	22586326
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPRASP1 NCOR2 CENPF ARHGEF7 CAMSAP3 ZFR RIMBP2 HUWE1 FSCN1 BCOR PARD3 PEX5L GOLGA1 PRRC2B	1.82e-07	963	90	14	28671696
Pubmed	Interaction network of human early embryonic transcription factors.	NCOR2 KMT2C ARID3A EP400 ARID4A NCOA1 BCOR TFAP4 PRRC2B	3.38e-07	351	90	9	38297188
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PJA2 KRT77 CGN SPATA18 CAMSAP3 TJP2 ALPK1 CRYBG3 BRD1 SIPA1L2 PARD3 KIF13A HECTD1	3.40e-07	861	90	13	36931259
Pubmed	RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers.	KRT2 PXDN KRT75 KRT77 ANXA11	3.90e-07	57	90	5	31862882
Pubmed	USP7 Regulates Cytokinesis through FBXO38 and KIF20B.	NCOR2 EP400 CENPF BCOR TFAP4 PRRC2B	5.99e-07	116	90	6	30804394
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOR2 SH2D4A EP400 ARID4A CAMSAP3 TJP2 ATM HUWE1 ODF2 BCOR PARD3 TFAP4	7.60e-07	774	90	12	15302935
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	USP34 NCOR2 ARID3A EP400 CENPF HUWE1 BCOR SIPA1L2 ZNF467	9.21e-07	396	90	9	26687479
Pubmed	Lulu2 regulates the circumferential actomyosin tensile system in epithelial cells through p114RhoGEF.	CGN TJP2 PARD3	9.30e-07	8	90	3	22006950
Pubmed	Engagement of the G3BP2-TRIM25 Interaction by Nucleocapsid Protein Suppresses the Type I Interferon Response in SARS-CoV-2-Infected Cells.	ARID3A KRT77 TMPRSS4 ATM SPAG17	1.66e-06	76	90	5	36560452
Pubmed	A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.	USP34 ATM HUWE1	1.98e-06	10	90	3	17478428
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	SH2D4A TMEM132D CAMSAP3 RIMBP2 ELL	2.14e-06	80	90	5	19389623
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOR2 ARID3A EP400 BCOR TFAP4	2.57e-06	83	90	5	28794006
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	USP34 NCOR2 EP400 TACC2 CRYBG3 CNTLN HUWE1 BCOR SIPA1L2 PRRC2B	3.01e-06	588	90	10	38580884
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KRT2 PXDN KRT75 CENPF KRT77 CAMSAP3 FAM169A ZFR CHD2 ATM ODF2 SIPA1L2 SPAG17 PRRC2B PRPH	4.21e-06	1442	90	15	35575683
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 ABCC3 NCOR2 KMT2C ARID3A EP400 ANXA11 LAMA5 HUWE1 SIPA1L2 HECTD1 ELL PRRC2B	5.35e-06	1105	90	13	35748872
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP34 KRT2 NEO1 EP400 VPS13C TMF1 TJP2 ZFR HUWE1 PARD3 PRRC2B	5.40e-06	777	90	11	35844135
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	KMT2C XIRP2 CENPF CAMSAP3 TJP2 ZFR CHD2 ATM GOLGA1	5.86e-06	497	90	9	36774506
Pubmed	Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice.	USP34 ATM	6.62e-06	2	90	2	37043976
Pubmed	A human-specific gene in microglia.	SIGLEC16 SIGLEC11	6.62e-06	2	90	2	16151003
Pubmed	SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans.	SIGLEC16 SIGLEC11	6.62e-06	2	90	2	18629938
Pubmed	Neurons in Vulnerable Regions of the Alzheimer's Disease Brain Display Reduced ATM Signaling.	PSEN1 ATM	6.62e-06	2	90	2	27022623
Pubmed	Ataxia telangiectasia mutated (ATM) interacts with p400 ATPase for an efficient DNA damage response.	EP400 ATM	6.62e-06	2	90	2	27814680
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ABCC3 KMT2C ARID4A ARHGEF7 MCM9 FAM169A NCOA1 CCDC178 BRD1 ATL2 HECTD1 TFAP4 ELL SLC26A6	7.79e-06	1327	90	14	32694731
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	GPRASP1 PJA2 KRT77 KLHL42 TJP2 ZFR RIMBP2 HUWE1 HECTD1 TFAP4 ELL PRRC2B	1.10e-05	1005	90	12	19615732
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	PJA2 SH2D4A VPS13C CGN CAMSAP3 TJP2 CNTLN ODF2 SIPA1L2 ELL PRRC2B	1.29e-05	853	90	11	28718761
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KMT2C EP400 CGN TJP2 ZFR HUWE1 BCOR PARD3 PRRC2B	1.30e-05	549	90	9	38280479
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 NCOR2 CENPF CAMSAP3 TMF1 CRYBG3 HUWE1 BCOR	1.34e-05	418	90	8	34709266
Pubmed	SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders.	SIGLEC16 SIGLEC11	1.98e-05	3	90	2	24859880
Pubmed	A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.	NCOR2 BCOR	1.98e-05	3	90	2	23911289
Pubmed	Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction.	XIRP2 STYXL2	1.98e-05	3	90	2	20520587
Pubmed	Inhibition effect of cypermethrin mediated by co-regulators SRC-1 and SMRT in interleukin-6-induced androgen receptor activation.	NCOR2 NCOA1	1.98e-05	3	90	2	27239967
Pubmed	The role of Siglec-G on B cells in autoimmune disease and leukemia.	SIGLEC16 SIGLEC11	1.98e-05	3	90	2	38042621
Pubmed	The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells.	SIGLEC16 SIGLEC11	1.98e-05	3	90	2	24790146
Pubmed	Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors.	NCOR2 NCOA1	1.98e-05	3	90	2	9751500
Pubmed	ATM-mediated ELL phosphorylation enhances its self-association through increased EAF1 interaction and inhibits global transcription during genotoxic stress.	ATM ELL	1.98e-05	3	90	2	36305813
Pubmed	Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population.	SIGLEC16 SIGLEC11	1.98e-05	3	90	2	17572677
Pubmed	Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.	SIGLEC16 SIGLEC11	1.98e-05	3	90	2	23836061
Pubmed	Evidence for a functional interaction between cingulin and ZO-1 in cultured cells.	CGN TJP2	1.98e-05	3	90	2	12023291
Pubmed	Human and Xenopus cingulin share a modular organization of the coiled-coil rod domain: predictions for intra- and intermolecular assembly.	CGN TJP2	1.98e-05	3	90	2	11042084
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	USP34 NEO1 EP400 VPS13C TMF1 TJP2 HUWE1 ATL2 HECTD1 SLC26A6	2.04e-05	733	90	10	34672954
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	USP34 NCOR2 KMT2C NCOA1 ZFR BCOR	2.39e-05	220	90	6	35785414
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	ZFR HUWE1 BCOR SIPA1L2 HECTD1 TFAP4	3.22e-05	232	90	6	25515538
Pubmed	BCOR modulates transcriptional activity of a subset of glucocorticoid receptor target genes involved in cell growth and mobility.	NCOR2 BCOR PRRC2B	3.26e-05	24	90	3	33722704
Pubmed	Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation.	SIGLEC16 SIGLEC11	3.96e-05	4	90	2	17912374
Pubmed	Polymorphism in MIR4697 but not VPS13C, GCH1, or SIPA1L2 is associated with risk of Parkinson's disease in a Han Chinese population.	VPS13C SIPA1L2	3.96e-05	4	90	2	28380328
Pubmed	Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.	SIGLEC16 SIGLEC11	3.96e-05	4	90	2	20038598
Pubmed	CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.	SIGLEC16 SIGLEC11	3.96e-05	4	90	2	20200274
Pubmed	Siglec-G regulates B1 cell survival and selection.	SIGLEC16 SIGLEC11	3.96e-05	4	90	2	20729333
Pubmed	Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK.	NCOR2 BCOR	3.96e-05	4	90	2	15878880
Pubmed	Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.	SIGLEC16 SIGLEC11	3.96e-05	4	90	2	30143587
Pubmed	hScrib interacts with ZO-2 at the cell-cell junctions of epithelial cells.	ARHGEF7 TJP2	3.96e-05	4	90	2	15975580
Pubmed	ATM and SIRT6/SNF2H Mediate Transient H2AX Stabilization When DSBs Form by Blocking HUWE1 to Allow Efficient γH2AX Foci Formation.	ATM HUWE1	3.96e-05	4	90	2	26711340
Pubmed	Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.	SIGLEC16 SIGLEC11	3.96e-05	4	90	2	24695850
Pubmed	Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin.	CGN TJP2	3.96e-05	4	90	2	10613913
Pubmed	The co-regulators SRC-1 and SMRT are involved in interleukin-6-induced androgen receptor activation.	NCOR2 NCOA1	3.96e-05	4	90	2	28396297
Pubmed	The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.	ATM HUWE1	3.96e-05	4	90	2	22213803
Pubmed	Siglecs induce tolerance to cell surface antigens by BIM-dependent deletion of the antigen-reactive B cells.	SIGLEC16 SIGLEC11	3.96e-05	4	90	2	25252961
Pubmed	Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.	NCOR2 NCOA1	3.96e-05	4	90	2	20003447
Pubmed	A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.	NCOR2 NCOA1	3.96e-05	4	90	2	20543827
Pubmed	Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice.	SIGLEC16 SIGLEC11	3.96e-05	4	90	2	24600033
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	SH2D4A CENPF CAMSAP3 TMF1 TJP2 TACC2 HUWE1 KIF13A	4.97e-05	503	90	8	16964243
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	MKRN4P ARID3A PXDN TJP2 RIMBP2 BCOR PRRC2B	5.19e-05	371	90	7	15747579
Pubmed	Thr176 regulates the activity of the mouse nuclear receptor CAR and is conserved in the NR1I subfamily members PXR and VDR.	NCOR2 NCOA1	6.59e-05	5	90	2	15610065
Pubmed	Coregulatory protein-orphan nuclear receptor interactions in the human adrenal cortex.	NCOR2 NCOA1	6.59e-05	5	90	2	16002533
Pubmed	Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus.	SIGLEC16 SIGLEC11	6.59e-05	5	90	2	36969253
Pubmed	Developmentally regulated expression of Netrin-1 and -3 in the embryonic mouse molar tooth germ.	NEO1 PRPH	6.59e-05	5	90	2	12889066
Pubmed	Activity-Based Probes for HECT E3 Ubiquitin Ligases.	HUWE1 HECTD1	6.59e-05	5	90	2	28425671
Pubmed	CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.	SIGLEC16 SIGLEC11	6.59e-05	5	90	2	19264983
Pubmed	The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.	NCOR2 NCOA1	6.59e-05	5	90	2	10757795
Pubmed	Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity.	KDM4C NCOA1	6.59e-05	5	90	2	29077881
Pubmed	Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA.	NCOR2 NCOA1	6.59e-05	5	90	2	10082574
Pubmed	Siglec-G Deficiency Leads to Autoimmunity in Aging C57BL/6 Mice.	SIGLEC16 SIGLEC11	6.59e-05	5	90	2	25987743
Pubmed	B Lymphocyte-Derived CCL7 Augments Neutrophil and Monocyte Recruitment, Exacerbating Acute Kidney Injury.	SIGLEC16 SIGLEC11	6.59e-05	5	90	2	32737150
Pubmed	Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.	NCOR2 NCOA1	6.59e-05	5	90	2	14715875
Pubmed	Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics.	NCOR2 NCOA1	6.59e-05	5	90	2	12072427
Pubmed	The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation.	SIGLEC16 SIGLEC11	6.59e-05	5	90	2	27548433
Pubmed	Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells.	SIGLEC16 SIGLEC11	6.59e-05	5	90	2	26947073
Pubmed	Coactivator and corepressor gene expression in rat cerebellum during postnatal development and the effect of altered thyroid status.	NCOR2 NCOA1	6.59e-05	5	90	2	10803578
Pubmed	Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300.	NCOR2 NCOA1	6.59e-05	5	90	2	14985122
Pubmed	A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing.	SIGLEC16 SIGLEC11	6.59e-05	5	90	2	21623346
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 KMT2C EP400 ARHGEF7 VPS13C KLHL42 LAMA5 BCOR	7.07e-05	529	90	8	14621295
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	NCOR2 ANXA11 TJP2 TACC2 ODF2 BRD1 PARD3 HECTD1	7.74e-05	536	90	8	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	NCOR2 ANXA11 TJP2 TACC2 ODF2 BRD1 PARD3 HECTD1	7.94e-05	538	90	8	10512203
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	KRT2 NCOR2 SH2D4A CGN CAMSAP3 TMF1 CRYBG3 HUWE1 ODF2 BCOR PRRC2B	8.44e-05	1049	90	11	27880917
Pubmed	Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.	NCOR2 NCOA1	9.87e-05	6	90	2	17312272
Pubmed	Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons.	SCN10A PRPH	9.87e-05	6	90	2	16029194
Pubmed	Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples.	PARD3 LGSN	9.87e-05	6	90	2	21621269
Pubmed	Molecular analysis of human Siglec-8 orthologs relevant to mouse eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G).	SIGLEC16 SIGLEC11	9.87e-05	6	90	2	14559209
Pubmed	Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.	SIGLEC16 SIGLEC11	9.87e-05	6	90	2	11986327
Pubmed	The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.	NCOR2 NCOA1	9.87e-05	6	90	2	9878542
Pubmed	Murine CENPF interacts with syntaxin 4 in the regulation of vesicular transport.	CENPF GOLGA1	9.87e-05	6	90	2	18827011
Pubmed	Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.	KRT75 ARHGEF7 SIGLEC16 SIGLEC11	1.12e-04	95	90	4	24029230
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RANBP17 NCOR2 KMT2C USF3 PXDN VPS13C CAMSAP3 ZNF189 CHD2 HUWE1 PARD3 HECTD1 TFAP4	1.18e-04	1489	90	13	28611215
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOR2 USF3 EP400 XIRP2 SCN10A ZFR ATM	1.30e-04	430	90	7	35044719
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	ARHGEF7 VPS13C CAMSAP3 TJP2 SIPA1L2 PARD3 PRPH	1.30e-04	430	90	7	32581705
Pubmed	A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells.	NCOR2 TFAP4	1.38e-04	7	90	2	16924111
Pubmed	Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors beta and gamma interferes with corepressor recruitment and prevents transcriptional repression.	NCOR2 NCOA1	1.38e-04	7	90	2	12665583
Pubmed	S 26948: a new specific peroxisome proliferator activated receptor gamma modulator with potent antidiabetes and antiatherogenic effects.	NCOR2 NCOA1	1.38e-04	7	90	2	17704298
Pubmed	MCM9 deficiency delays primordial germ cell proliferation independent of the ATM pathway.	MCM9 ATM	1.38e-04	7	90	2	26388201
Interaction	FBXO22 interactions	NCOR2 KMT2C XIRP2 CENPF KDM4C CAMSAP3 TJP2 ZFR CHD2 ATM FSCN1 GOLGA1	4.41e-06	540	89	12	int:FBXO22
Interaction	RHEB interactions	PJA2 PSEN1 FAM169A TJP2 ATM FSCN1 SIPA1L2	8.18e-06	164	89	7	int:RHEB
Interaction	NANOG interactions	USP34 NCOR2 KMT2C ARID3A EP400 CENPF ZFR HUWE1 BCOR SIPA1L2 ZNF467	8.72e-06	481	89	11	int:NANOG
Interaction	AMOT interactions	KRT75 CGN CAMSAP3 TJP2 CRYBG3 BCOR SIPA1L2 PARD3 HECTD1	9.77e-06	312	89	9	int:AMOT
Interaction	EGR2 interactions	NCOR2 KMT2C ARID3A EP400 NCOA1 BCOR PRRC2B	1.08e-05	171	89	7	int:EGR2
Interaction	SMG7 interactions	NCOR2 ARID3A TJP2 NCOA1 ODF2 BCOR GOLGA1 PRRC2B PRPH	1.17e-05	319	89	9	int:SMG7
Interaction	CRX interactions	NCOR2 KMT2C ARID3A EP400 NCOA1 ATM TFAP4 PRRC2B	1.67e-05	254	89	8	int:CRX
Interaction	RNF208 interactions	KRT2 PXDN KRT75 KRT77 ANXA11	2.03e-05	75	89	5	int:RNF208
Interaction	MYOD1 interactions	NCOR2 KMT2C ARID3A EP400 NCOA1 HUWE1 BCOR	2.43e-05	194	89	7	int:MYOD1
Interaction	KRT8 interactions	KRT2 PJA2 KRT75 KRT77 CAMSAP3 CRYBG3 SIPA1L2 PEX5L HECTD1 PRPH	2.47e-05	441	89	10	int:KRT8
Interaction	TCHP interactions	KRT75 TJP2 ODF2 PARD3 GOLGA1 PRPH	2.51e-05	131	89	6	int:TCHP
Interaction	CDH2 interactions	PSEN1 TMPRSS4 PARD3 PEX5L HECTD1 PRPH	3.51e-05	139	89	6	int:CDH2
Interaction	FBXO38 interactions	NCOR2 EP400 CENPF BCOR TFAP4 PRRC2B	4.45e-05	145	89	6	int:FBXO38
Interaction	SP7 interactions	NCOR2 KMT2C ARID3A EP400 NCOA1 ZFR BCOR PRRC2B	5.99e-05	304	89	8	int:SP7
Interaction	KRT84 interactions	KRT2 KRT75 KRT77 PRPH	6.47e-05	49	89	4	int:KRT84
Interaction	YWHAH interactions	PJA2 SNCAIP ARHGEF7 KRT77 CGN SPATA18 CAMSAP3 TJP2 NCOA1 CRYBG3 HUWE1 BRD1 SIPA1L2 PARD3 HECTD1	8.98e-05	1102	89	15	int:YWHAH
Interaction	KRT18 interactions	KRT2 KRT75 KRT77 CRYBG3 HUWE1 SIPA1L2 PEX5L HECTD1 PRPH	9.75e-05	419	89	9	int:KRT18
Interaction	SIRT7 interactions	USP34 CENPF ANXA11 CGN TJP2 ZFR CHD2 ATM HUWE1 FSCN1 HECTD1 PRRC2B	1.03e-04	744	89	12	int:SIRT7
Interaction	EN1 interactions	NCOR2 KMT2C ARID3A EP400 BCOR	1.27e-04	110	89	5	int:EN1
Interaction	TEAD1 interactions	NCOR2 KMT2C ARID3A NCOA1 BCOR TFAP4	1.30e-04	176	89	6	int:TEAD1
Interaction	PPP1R13B interactions	CENPF CGN TJP2 PARD3 GOLGA1 PRPH	1.30e-04	176	89	6	int:PPP1R13B
Interaction	AP1M2 interactions	PSEN1 TMF1 KIF13A HECTD1	1.43e-04	60	89	4	int:AP1M2
Interaction	KRT12 interactions	KRT2 KRT75 PRPH	1.58e-04	24	89	3	int:KRT12
Interaction	SIPA1L3 interactions	TJP2 ODF2 SIPA1L2 PARD3 PRPH	1.77e-04	118	89	5	int:SIPA1L3
Interaction	GATA3 interactions	NCOR2 ARID3A ZFR FSCN1 BCOR PRRC2B	1.81e-04	187	89	6	int:GATA3
Interaction	HNF1B interactions	NCOR2 KMT2C ARID3A EP400 BCOR PRRC2B	1.97e-04	190	89	6	int:HNF1B
Interaction	EYA2 interactions	NCOR2 CGN BCOR TEKT5 PRRC2B	1.99e-04	121	89	5	int:EYA2
Interaction	CEP135 interactions	CGN CAMSAP3 TJP2 CNTLN ODF2 SIPA1L2 PRRC2B	2.03e-04	272	89	7	int:CEP135
Interaction	KLF5 interactions	NCOR2 KMT2C ARID3A EP400 BCOR PRRC2B	2.27e-04	195	89	6	int:KLF5
Interaction	SFN interactions	KRT2 PJA2 KRT77 CGN CAMSAP3 TJP2 CRYBG3 SIPA1L2 PARD3 KIF13A HECTD1	2.31e-04	692	89	11	int:SFN
Interaction	GCM1 interactions	NCOR2 KMT2C BCOR PRRC2B	2.33e-04	68	89	4	int:GCM1
Interaction	ARL1 interactions	PSEN1 EP400 TMF1 HUWE1 FSCN1 GOLGA1	2.60e-04	200	89	6	int:ARL1
Interaction	KRT27 interactions	KRT2 KRT75 KRT77 CGN GOLGA1 PRPH	2.74e-04	202	89	6	int:KRT27
Interaction	FEV interactions	NCOR2 KMT2C ARID3A EP400 BCOR PRRC2B	2.82e-04	203	89	6	int:FEV
Interaction	PRPH interactions	KRT2 KRT75 VPS13C KRT77 CAMSAP3 PRPH	2.89e-04	204	89	6	int:PRPH
Interaction	KLF15 interactions	NCOR2 KMT2C ARID3A EP400 NCOA1 BCOR PRRC2B	2.99e-04	290	89	7	int:KLF15
Cytoband	12q24.33	EP400 TMEM132D RIMBP2	1.18e-04	48	90	3	12q24.33
Cytoband	Ensembl 112 genes in cytogenetic band chr12q24	NCOR2 EP400 DNAH10 TMEM132D RIMBP2	1.38e-03	415	90	5	chr12q24
Cytoband	3q13.2	USF3 GCSAM	1.70e-03	31	90	2	3q13.2
Cytoband	Xp21.1	MKRN4P H2AP	2.05e-03	34	90	2	Xp21.1
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	SH2D4A TMEM132D CAMSAP3 RIMBP2 PARD3 ELL	2.20e-05	181	57	6	694
GeneFamily	Keratins, type II	KRT2 KRT75 KRT77	8.24e-05	27	57	3	609
GeneFamily	AT-rich interaction domain containing	ARID3A ARID4A	9.99e-04	15	57	2	418
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NEO1 PXDN SIGLEC16 SIGLEC11	1.66e-03	161	57	4	593
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOR2 EP400	2.80e-03	25	57	2	775
GeneFamily	CD molecules\|C2-set domain containing\|Sialic acid binding Ig like lectins	SIGLEC16 SIGLEC11	3.50e-03	28	57	2	745
Coexpression	MURARO_PANCREAS_BETA_CELL	USP34 GPRASP1 PJA2 NCOR2 KMT2C NEO1 USF3 OSTM1 VPS13C KLHL42 HUWE1 SIPA1L2 KIF13A HECTD1 PRRC2B	6.48e-07	946	89	15	M39169
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	GPRASP1 PJA2 ARID4A MCM9 FAM169A TMF1 NCOA1 ZFR CHD2 BRD1 ATL2 SLC26A6	3.23e-06	680	89	12	M41089
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN	NCOR2 CGN TMPRSS4 CHD2 BRD1 KIF13A PRRC2B	4.66e-06	195	89	7	M9808
Coexpression	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN	DNAH10 ABCA13 ANXA11 CGN SPATA18 TMPRSS4 TACC2 SPAG17	3.02e-05	358	89	8	M12671
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	USP34 PJA2 NCOR2 ARID4A CENPF KDM4C ARHGEF7 FAM169A TJP2 NCOA1 CRYBG3 PARD3	3.22e-05	856	89	12	M4500
Coexpression	GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP	KRT2 NCOR2 CENPF NCOA1 TMPRSS4 ATM	6.29e-05	200	89	6	M3743
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KMT2C OTOGL VPS13C SCN10A SIGLEC11 CNTLN SPAG17	1.03e-07	186	90	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	DNAH10 ABCA13 CGN SPATA18 CIBAR2 TACC2 SPAG17	1.52e-07	197	90	7	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RANBP17 ABCC3 TMEM132D CGN LAMA5 TACC2	2.02e-06	184	90	6	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 ABCA13 TMPRSS4 RIMBP2 CCDC178 SPAG17	2.43e-06	190	90	6	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP34 USF3 CRYBG3 HUWE1 BCOR HECTD1	2.66e-06	193	90	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DNAH10 ABCA13 CGN SPATA18 CIBAR2 SPAG17	2.74e-06	194	90	6	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	DNAH10 SPATA18 CIBAR2 TACC2 PARD3 SPAG17	2.82e-06	195	90	6	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	ABCA13 SPATA18 TMPRSS4 TACC2 PARD3 SPAG17	2.91e-06	196	90	6	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	ABCA13 SPATA18 TMPRSS4 TACC2 PARD3 SPAG17	2.91e-06	196	90	6	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	DNAH10 SPATA18 CIBAR2 TACC2 PARD3 SPAG17	2.91e-06	196	90	6	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 KMT2C SNCAIP KDM4C FAM169A ATM	2.99e-06	197	90	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	BL-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ABCA13 CGN TMPRSS4 CIBAR2 TACC2 PARD3	3.08e-06	198	90	6	6218a25b94d5fa2c69880539adf9c63bfe52dcd3
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ABCA13 CGN CIBAR2 TACC2 SPAG17	3.17e-06	199	90	6	1ee4010d8557564e25e8ee00b914c2dfd9037838
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ABCA13 CGN CIBAR2 TACC2 SPAG17	3.17e-06	199	90	6	1df69c0cb5f759f6a2152521842506a75bb95cae
ToppCell	Mild-Epithelial-Epithelial-\|Mild / Condition, Lineage, Cell class and cell subclass	DNAH10 ABCA13 CGN CIBAR2 TACC2 SPAG17	3.17e-06	199	90	6	81115bbd2c10bfdd38376d2075f03a59c31870d2
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ABCA13 CGN CIBAR2 TACC2 SPAG17	3.17e-06	199	90	6	74087b4b5e567310fc4ac58fb267ff651a180680
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ABCA13 CGN CIBAR2 TACC2 SPAG17	3.17e-06	199	90	6	00b5ce099c50a5e1786ce2b3a06ee0931a8205a4
ToppCell	Mild-Epithelial\|Mild / Condition, Lineage, Cell class and cell subclass	DNAH10 ABCA13 CGN CIBAR2 TACC2 SPAG17	3.17e-06	199	90	6	ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18
ToppCell	Mild-Epithelial-Epithelial\|Mild / Condition, Lineage, Cell class and cell subclass	DNAH10 ABCA13 CGN CIBAR2 TACC2 SPAG17	3.17e-06	199	90	6	91308b255783ad4029e5575028c18d7550832c51
ToppCell	Mild_COVID-19-Epithelial\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DNAH10 ABCA13 CGN CIBAR2 TACC2 SPAG17	3.17e-06	199	90	6	72689bda7476930887ae007682fcab27f956f050
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ABCA13 CGN TJP2 LAMA5 TMPRSS4 HECTD1	3.27e-06	200	90	6	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	DNAH10 ABCA13 TMPRSS4 TACC2 SPAG17	1.39e-05	151	90	5	8216462e723fec2797387929dde095370947e10a
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 OTOGL ABCA13 SCN10A CCDC178	1.95e-05	162	90	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	AT1-AT2_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	RANBP17 PXDN KRT75 TMEM132D CRISPLD1	1.95e-05	162	90	5	57d627259d27f39885bf416d74bcb6656db6e27b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RANBP17 ABCC3 TMEM132D ABCA13 RIMBP2	2.07e-05	164	90	5	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	LPS-antiTNF-Epithelial_airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SH2D4A SPATA18 TMPRSS4 CIBAR2 SPAG17	2.20e-05	166	90	5	eb942ed68677e55c46cb039046f45686d4062d7c
ToppCell	15-Distal-Epithelial-Multiciliated_cell\|Distal / Age, Tissue, Lineage and Cell class	DNAH10 SPATA18 CIBAR2 SPAG17 LGSN	2.39e-05	169	90	5	425d89ab69e9f9eb3df84056676423e390cc6ab1
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	2.68e-05	173	90	5	c3762655caa79ac4879876f470d32578a3c93b01
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDM4C VPS13C TMPRSS4 RIMBP2 PEX5L	2.75e-05	174	90	5	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	AT1_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	RANBP17 ARID4A TMEM132D CGN LAMA5	2.91e-05	176	90	5	458720776b0151cd55acc352d509599cb62f0ca8
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH10 SPATA18 CIBAR2 SPAG17 LGSN	3.07e-05	178	90	5	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	RANBP17 CGN LAMA5 TACC2 PARD3	3.15e-05	179	90	5	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF7 SIPA1L2 ZNF467 PEX5L PRPH	3.24e-05	180	90	5	a37cc885fe3f6cb9df69d43358064c83c18412e7
ToppCell	facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF7 SIPA1L2 ZNF467 PEX5L PRPH	3.24e-05	180	90	5	63a6d532b16b8b15c7c9102148d7297ee3afd641
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	3.24e-05	180	90	5	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH10 SPATA18 CIBAR2 SPAG17 LGSN	3.32e-05	181	90	5	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	3.41e-05	182	90	5	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	COPD-Epithelial-ATI\|World / Disease state, Lineage and Cell class	RANBP17 CGN LAMA5 TACC2 PARD3	3.41e-05	182	90	5	e95d946a43b1579af199900bb0e3eacbb9d65300
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 XIRP2 OTOGL ABCA13 SPAG17	3.59e-05	184	90	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 XIRP2 OTOGL ABCA13 SPAG17	3.59e-05	184	90	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 XIRP2 OTOGL ABCA13 SPAG17	3.59e-05	184	90	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	3.59e-05	184	90	5	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	Control-Epithelial-ATI\|World / Disease state, Lineage and Cell class	RANBP17 CGN LAMA5 TACC2 PARD3	3.69e-05	185	90	5	0563d5042bb96ecce8446fbf26d05ef7a45e23c5
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	3.69e-05	185	90	5	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	3.78e-05	186	90	5	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	COPD-Epithelial-ATI\|COPD / Disease state, Lineage and Cell class	RANBP17 CGN LAMA5 TACC2 PARD3	3.78e-05	186	90	5	df0977f6f48a2d4e11b59971f098b01204242f0f
ToppCell	COPD-Epithelial-Ciliated\|COPD / Disease state, Lineage and Cell class	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	3.88e-05	187	90	5	f0fd0792f6926f705d175f6e6fd480f12c7a3bd4
ToppCell	Control-Epithelial-ATI\|Control / Disease state, Lineage and Cell class	RANBP17 CGN LAMA5 TACC2 PARD3	3.88e-05	187	90	5	fdd1c57b61ca9392ac27661a82729f37593df63c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA11 TMPRSS4 RIMBP2 CCDC178 HECTD1	3.88e-05	187	90	5	77886f99c229610abd28c4c370d2c7d1536c9782
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA11 CGN TMPRSS4 CCDC178 HECTD1	3.88e-05	187	90	5	f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 KMT2C VPS13C CHD2 HUWE1	3.98e-05	188	90	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	3.98e-05	188	90	5	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	3.98e-05	188	90	5	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 CGN SPATA18 CIBAR2 SPAG17	3.98e-05	188	90	5	0eca3dc93724e23b71e687fc24fa9f1e89bdef6a
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	3.98e-05	188	90	5	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAH10 CGN SPATA18 CIBAR2 SPAG17	3.98e-05	188	90	5	9ce3e1fffce87ad19812ecbf9b7f9935a975d676
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.08e-05	189	90	5	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.08e-05	189	90	5	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Control-Epithelial-Ciliated\|Control / Disease state, Lineage and Cell class	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.08e-05	189	90	5	c007fccd08728db3ea99af9da91d67b9b16dabb3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANXA11 CGN TMPRSS4 CCDC178 HECTD1	4.08e-05	189	90	5	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.08e-05	189	90	5	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.08e-05	189	90	5	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.08e-05	189	90	5	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	7b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 CENPF ABCA13 SPATA18 CIBAR2	4.29e-05	191	90	5	683e5c7e6173644f01e67c98ab7b75d7cb9cce99
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	fa9f8b50bfc7911c858bc2f9dcd204873d97ac61
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	DNAH10 ABCA13 TMPRSS4 CIBAR2 SPAG17	4.29e-05	191	90	5	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	Healthy_Control-Epithelial-Epithelial-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	28caedb2e448e0c7f494100d714fa7cdcf150691
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	b4e335e798c9617356b8e24412f9270c42dce656
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	c4b223b33c020a064f576711a3d700eb60a2d737
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	RANBP17 CGN TMPRSS4 TACC2 PARD3	4.29e-05	191	90	5	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	df8a1a6e78aa0cb941b94cb676bd6891d79f3687
ToppCell	Healthy_Control-Epithelial-Epithelial\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	15b9386b26caaa7d15f704c4a18881e1ce918a21
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 TMPRSS4 RIMBP2 CCDC178 SPAG17	4.29e-05	191	90	5	5a67ff17fb4b9eff641176dff07830c9cd73754e
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.29e-05	191	90	5	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 TMPRSS4 RIMBP2 CCDC178 SPAG17	4.29e-05	191	90	5	55ab2854a02cdcfc395e49870ccb7290b5e5471d
ToppCell	Control-Epithelial\|Control / Disease group,lineage and cell class （2021.01.30）	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	b78547dae8328244a47c83346447bdd787efbcae
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.29e-05	191	90	5	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.29e-05	191	90	5	e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a
ToppCell	Healthy_Control-Epithelial\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde
ToppCell	Control-Epithelial-Ciliated\|Control / Disease group,lineage and cell class （2021.01.30）	DNAH10 ABCA13 CIBAR2 TACC2 SPAG17	4.29e-05	191	90	5	cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	DNAH10 ABCA13 TMPRSS4 CIBAR2 SPAG17	4.29e-05	191	90	5	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.29e-05	191	90	5	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.40e-05	192	90	5	03acd4a26b986e34eee608747347791122f1aa52
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.40e-05	192	90	5	31c6046589e2fbb0486fd044c5b128099d37872f
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.40e-05	192	90	5	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.51e-05	193	90	5	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCC3 ARID3A CGN TMPRSS4 LGSN	4.51e-05	193	90	5	32eb026d4317c1499d51294d396dfd5f293f9deb
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.51e-05	193	90	5	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCC3 ARID3A CGN TMPRSS4 LGSN	4.51e-05	193	90	5	930df79b0600f43617052313294be33bcf5631f0
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCC3 ARID3A CGN TMPRSS4 LGSN	4.62e-05	194	90	5	07d8e38cbc2c7f0564c14f7c365f345f901b73b2
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	USP34 GPRASP1 PJA2 FAM169A ZFR	4.62e-05	194	90	5	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	Control-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.62e-05	194	90	5	958e648138676d46698090b4046cb484083ae449
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.62e-05	194	90	5	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.74e-05	195	90	5	79dc031258579ea328181dda33710dd897f1064a
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH10 ABCA13 SPATA18 CIBAR2 SPAG17	4.74e-05	195	90	5	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2C VPS13C NCOA1 ZFR HUWE1	4.74e-05	195	90	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2C VPS13C NCOA1 ZFR HUWE1	4.74e-05	195	90	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RANBP17 TJP2 TMPRSS4 FSCN1 LGSN	4.97e-05	197	90	5	4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1
Drug	Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A	USP34 GPRASP1 SH2D4A CENPF RIMBP2 ATM BCOR TFAP4	1.15e-06	197	90	8	6018_DN
Drug	Natamycin [7681-93-8]; Down 200; 6uM; MCF7; HT_HG-U133A	ABCC3 SH2D4A PSEN1 ARID4A ALPK1 FSCN1 ZNF467 SLC26A6	1.29e-06	200	90	8	7167_DN
Drug	Trichlorfon [52-68-6]; Down 200; 15.6uM; PC3; HT_HG-U133A	USP34 MCM9 NCOA1 BRD1 PARD3 GOLGA1 SLC26A6	1.33e-05	197	90	7	7287_DN
Drug	Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A	USP34 PJA2 FAM169A NCOA1 PARD3 GOLGA1 SLC26A6	1.33e-05	197	90	7	3444_DN
Drug	Fluorometholone [426-13-1]; Down 200; 10.6uM; PC3; HT_HG-U133A	CENPF KDM4C MCM9 FAM169A NCOA1 ATM FSCN1	1.33e-05	197	90	7	5771_DN
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	USP34 ATM ALPK1 PARD3 ATL2 KIF13A ELL	1.47e-05	200	90	7	4824_DN
Drug	auto inducer 2	TAS2R10 PSEN1 ATM	9.99e-05	23	90	3	CID000448719
Drug	NSC325316	NCOR2 NCOA1 LGSN	9.99e-05	23	90	3	CID000331608
Drug	F0447-0125; Up 200; 10uM; PC3; HT_HG-U133A	RANBP17 USP34 PSEN1 CENPF ARHGEF7 FSCN1	1.09e-04	190	90	6	6429_UP
Drug	carmustine; Up 200; 100uM; MCF7; HT_HG-U133A	USP34 OSTM1 KDM4C TMF1 ATM PRPH	1.15e-04	192	90	6	6914_UP
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A	USP34 ANXA11 TMPRSS4 ATM ZNF467 TFAP4	1.15e-04	192	90	6	3382_DN
Drug	Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A	SH2D4A FAM169A NCOA1 ALPK1 PARD3 ZNF467	1.15e-04	192	90	6	6044_DN
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	USP34 ABCC3 PSEN1 CENPF ATM ALPK1	1.18e-04	193	90	6	3667_DN
Drug	Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A	GPRASP1 ABCC3 TAS2R10 CENPF ATM ALPK1	1.22e-04	194	90	6	3345_UP
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A	GPRASP1 ABCC3 FAM169A FSCN1 PARD3 SLC26A6	1.25e-04	195	90	6	6834_DN
Drug	leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA	CENPF VPS13C ANXA11 TMF1 TACC2 ATM	1.25e-04	195	90	6	1108_UP
Drug	Sulfathiazole [72-14-0]; Up 200; 15.6uM; PC3; HG-U133A	ABCC3 ARID4A ZNF189 FAM169A FSCN1 TRIM5	1.25e-04	195	90	6	1883_UP
Drug	Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A	ABCC3 SNCAIP VPS13C SCN10A FAM169A TFAP4	1.29e-04	196	90	6	1515_UP
Drug	5162773; Down 200; 7uM; MCF7; HT_HG-U133A_EA	ARID4A TMPRSS4 ATM ALPK1 FSCN1 TRIM5	1.29e-04	196	90	6	892_DN
Drug	Aminophylline [317-34-0]; Down 200; 9.6uM; PC3; HT_HG-U133A	USP34 ABCC3 EP400 ZFR PRRC2B PRPH	1.29e-04	196	90	6	6295_DN
Drug	Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A	ABCC3 NCOR2 CENPF TMPRSS4 ARHGAP25 FSCN1	1.29e-04	196	90	6	4752_UP
Drug	Solanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A	TAS2R10 SNCAIP ARHGEF7 SCN10A FSCN1 PARD3	1.29e-04	196	90	6	4166_DN
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	USP34 ZFR ATM FSCN1 PARD3 SLC26A6	1.29e-04	196	90	6	4697_DN
Drug	Sulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	USP34 ZNF189 SCN10A ALPK1 HUWE1 KIF13A	1.32e-04	197	90	6	1467_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	SH2D4A ARHGEF7 MCM9 ATM ALPK1 SLC26A6	1.32e-04	197	90	6	1634_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA	USP34 ABCC3 KDM4C ARHGEF7 ANXA11 ALPK1	1.32e-04	197	90	6	1042_UP
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	NEO1 SH2D4A ARID3A KDM4C ALPK1 PRRC2B	1.36e-04	198	90	6	7180_DN
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HG-U133A	ABCC3 ZFR ATM TFAP4 GOLGA1 PRRC2B	1.36e-04	198	90	6	762_UP
Drug	Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; HL60; HT_HG-U133A	USP34 KDM4C ARHGEF7 NCOA1 ZFR PARD3	1.36e-04	198	90	6	1298_DN
Drug	Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; PC3; HT_HG-U133A	ABCC3 ZFR ODF2 GOLGA1 ELL PRRC2B	1.36e-04	198	90	6	1816_DN
Drug	Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	ARID3A ANXA11 NCOA1 ALPK1 FSCN1 GOLGA1	1.36e-04	198	90	6	7415_DN
Drug	Spironolactone [52-01-7]; Up 200; 9.6uM; HL60; HG-U133A	KDM4C ANXA11 ZFR ATM ALPK1 ODF2	1.36e-04	198	90	6	1380_UP
Drug	quercetin dihydrate; Down 200; 1uM; MCF7; HT_HG-U133A_EA	USP34 ARID3A ZNF189 ATM FSCN1 PRPH	1.36e-04	198	90	6	917_DN
Drug	Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A	USP34 TMPRSS4 ATM ALPK1 FSCN1 ATL2	1.36e-04	198	90	6	3264_DN
Drug	Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	FAM169A ATM FSCN1 GOLGA1 SLC26A6 PRRC2B	1.36e-04	198	90	6	3466_DN
Drug	rotenone; Down 200; 1uM; MCF7; HT_HG-U133A	GPRASP1 NCOR2 FAM169A TMPRSS4 FSCN1 TRIM5	1.36e-04	198	90	6	5915_DN
Drug	Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A	ABCC3 FAM169A FSCN1 BCOR TFAP4 TRIM5	1.40e-04	199	90	6	3224_DN
Drug	Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A	RANBP17 ARID3A PXDN EP400 FAM169A FSCN1	1.40e-04	199	90	6	5295_DN
Drug	Pyrilamine maleate [59-33-6]; Up 200; 10uM; HL60; HG-U133A	USP34 PSEN1 OSTM1 CENPF FSCN1 PRRC2B	1.40e-04	199	90	6	1568_UP
Drug	Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A	SH2D4A ARID3A FAM169A FSCN1 TRIM5 PRRC2B	1.40e-04	199	90	6	7233_DN
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; PC3; HT_HG-U133A	CENPF KDM4C NCOA1 ALPK1 ZNF467 TFAP4	1.44e-04	200	90	6	6679_DN
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	USP34 GPRASP1 ZFR ALPK1 ODF2 FSCN1	1.44e-04	200	90	6	2075_DN
Disease	Parkinson disease, disease progression measurement	SNCAIP PARD3 CRISPLD1	1.89e-04	39	84	3	EFO_0008336, MONDO_0005180
Disease	Adenoid Cystic Carcinoma	KMT2C ATM BRD1 BCOR	1.95e-04	100	84	4	C0010606
Disease	Dupuytren Contracture	PJA2 PXDN TACC2 ELL	2.61e-04	108	84	4	EFO_0004229
Disease	severe acute respiratory syndrome, COVID-19	ABCC3 PXDN ARHGEF7 RIMBP2 CCDC178 SIPA1L2 PARD3	2.90e-04	447	84	7	EFO_0000694, MONDO_0100096
Disease	Prostatic Neoplasms	KMT2C ARID4A CENPF SPATA18 TMF1 NCOA1 ATM PARD3	3.73e-04	616	84	8	C0033578
Disease	Malignant neoplasm of prostate	KMT2C ARID4A CENPF SPATA18 TMF1 NCOA1 ATM PARD3	3.73e-04	616	84	8	C0376358
Disease	polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement	PEX5L TRIM5	4.33e-04	11	84	2	EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964
Disease	atrial fibrillation	USP34 NCOR2 DNAH10 SCN10A ALPK1 MYZAP	6.76e-04	371	84	6	EFO_0000275
Disease	serum IgG glycosylation measurement	USF3 PXDN DNAH10 TMEM132D VPS13C CHD2 TRIM5	7.37e-04	523	84	7	EFO_0005193
Disease	phosphoenolpyruvic acid measurement	KDM4C RIMBP2	8.21e-04	15	84	2	EFO_0010522
Disease	lung adenocarcinoma	NCOA1 ATM CNTLN TEKT5	1.56e-03	174	84	4	EFO_0000571
Disease	stomach carcinoma (is_marker_for)	KMT2C KDM4C	2.12e-03	24	84	2	DOID:5517 (is_marker_for)
Disease	migraine disorder, diastolic blood pressure	NCOR2 ARID4A	2.30e-03	25	84	2	EFO_0006336, MONDO_0005277

Protein segments in the cluster

Peptide	Gene	Start	Entry
EQQANQENMSSRTDS	nan	21	A8MT66
ENASSEQRQELMRSF	EP400	1946	Q96L91
QSQRSSQQRENDEEM	BRD1	501	O95696
SRDSQVRVMENTVAN	CIBAR2	6	Q6ZTR7
RQSMAQAEEETRSRS	ELL	131	P55199
SFQLNELDNMNSTER	ARID4A	1171	P29374
LSQGNRDESTNVDMS	ANXA11	341	P50995
SNEAMLRQSVTNLQD	CNTLN	396	Q9NXG0
NSTVMSNRTLVQREE	CRYBG3	411	Q68DQ2
QGQDLSTDSRTNRDM	BTNL8	171	Q6UX41
NETQTFSMDSVNLRE	ABCA13	2661	Q86UQ4
KRQDSQNENERMSST	GCSAM	56	Q8N6F7
SLDMTDNSNNQLVVR	ARHGEF7	176	Q14155
ADSSQLSREQRALQM	BCOR	986	Q6W2J9
SSLQRDMQRLTDQQQ	CAMSAP3	711	Q9P1Y5
SRSQDREALSQEVMS	ALPK1	396	Q96QP1
LVEMNTNEAESRNSN	MKRN4P	176	Q13434
LMQNRSQRLNFDVSS	RANBP17	776	Q9H2T7
KRDNSSNGRMDNNSQ	GSG1L2	56	A8MUP6
TNDAMADSRQNNTSL	ABCC3	996	O15438
RITRSMANEANSEEA	NCOR2	581	Q9Y618
TVEGENDTMSNAQRS	KMT2C	1621	Q8NEZ4
EASNNGSMRNTSQDR	H2AP	71	O75409
TRELSRTQEELMNSN	GOLGA1	206	Q92805
MQQLDSNLNSTRSQC	SPATA18	121	Q8TC71
ERTSQNSELNNMQDL	KRT2	246	P35908
MRLANFQTDSQESIQ	CCDC178	821	Q5BJE1
EMNESRRQIQSLTCE	PRPH	311	P41219
LTMTSQLVNEQQESR	PEX5L	61	Q8IYB4
TREQSRRMAASNISN	FBXO8	26	Q9NRD0
EESSASRMQVEQNLS	KDM4C	431	Q9H3R0
DTATRVQSQLQAMQE	LAMA5	2641	O15230
MDNISRAAGNTSESQ	OSTM1	126	Q86WC4
SQASTLQANREDSMN	HUWE1	2391	Q7Z6Z7
LGQSNMDSENTRDAQ	ATM	1001	Q13315
ARTNATNNMNLSRSS	HECTD1	1556	Q9ULT8
RNVSTRQGMDLSANQ	FSCN1	271	Q16658
RSEMTDNQNNSKSEA	CENPF	1111	P49454
QRMDTTGRTILENNS	CHD2	941	O14647
DDSSRNEVISAQQMS	CRISPLD1	276	Q9H336
DNLMEENIRQSVTNS	ATL2	551	Q8NHH9
ARTEDNQSSEMQLTI	FAM169A	291	Q9Y6X4
SRTTSMDIQRNLEAN	DNAH10	2486	Q8IVF4
EGNETEANSMNTLRR	LGSN	16	Q5TDP6
SNDMTTSNNLEVRNA	OTOGL	1086	Q3ZCN5
VQMQRQRQEERESSQ	PARD3	1201	Q8TEW0
DRLEQSESTNRSMQN	ODF2	781	Q5BJF6
SRTVAATNMNEESSR	KIF13A	206	Q9H1H9
QMQRQSDCRNAARTT	MCM9	551	Q9NXL9
QEANTMSRSQTNQEL	GPRASP1	231	Q5JY77
QMQSNVTGLRDSNTE	TAS2R10	206	Q9NYW0
CRSESDMENERNSNT	RIMBP2	146	O15034
MSEDNHLSNTVRSQN	PSEN1	16	P49768
NQDIMRNSSLQSRVE	TMEM132D	66	Q14C87
INVNTSLEDMRSNNV	SLC26A6	611	Q9BXS9
SNMVSTRINRQQSSD	NCOA1	411	Q15788
MSLSDRANSTESVRN	NEO1	1291	Q92859
QDNMRLQEESQTATA	SIPA1L2	1691	Q9P2F8
MQRSLSESDTDSNNS	SNCAIP	671	Q9Y6H5
SQNMRANSIQLREEA	TEKT5	306	Q96M29
QNLSMSVQDNESNRE	SPAG17	676	Q6Q759
MSIRINSQASESRQD	ARID3A	491	Q99856
TEQLRRSMQDATQDH	CGN	526	Q9P2M7
TSRSSQEMARNEQEG	XIRP2	121	A4UGR9
NSETEMVQQTQSLRE	TRIM5	216	Q9C035
ESLTQEQRMFRENTN	ZNF189	121	O75820
MESQNSLLRQENSRF	TMF1	831	P82094
AQMRRAASSDQLRDN	TJP2	971	Q9UDY2
QGATQRSQMANSSRE	RASGEF1A	361	Q8N9B8
MSAQRLISNRTSQQS	MRAP2	1	Q96G30
RVNMRTSSSIQNEDE	SCN10A	1931	Q9Y5Y9
ERSRQTLEESQSMAS	STYXL2	631	Q5VZP5
MSQDLRQLSDSQRTS	ARHGAP25	486	P42331
RNNNELSMKTDSRLN	PXDN	281	Q92626
EITENSQELRMRNSS	TMPRSS4	166	Q9NRS4
RQRQLSMSSADSADA	PRRC2B	411	Q5JSZ5
SSRNIQQMLADSINR	SH2D4A	176	Q9H788
TSRMIDRKNDQDNNS	VPS13C	2011	Q709C8
SLRSMQSQAFRISQN	USF3	1766	Q68DE3
MGNENSTSDNQRTLS	TACC2	1	O95359
TMTDQQREDITSSAQ	ZFR	1001	Q96KR1
QQRLSDTEESMQGSS	USP34	551	Q70CQ2
SRVITQRETENNQMT	PJA2	381	O43164
QRETENNQMTSESGA	PJA2	386	O43164
EIANSNERRRMQSIN	TFAP4	51	Q01664
VATNNQSREVEMSTR	SIGLEC11	86	Q96RL6
HNAQEQMSSSREERA	ZNF467	31	Q7Z7K2
TNNQSREVAMSTRDR	SIGLEC16	76	A6NMB1
NRRSSQSEDMLTVQS	KLHL42	406	Q9P2K6
DTNVILSMDNNRSLD	KRT77	316	Q7Z794
DTSVVLSMDNNRNLD	KRT75	301	O95678
QTQSSALDRFNAMNS	MYZAP	151	P0CAP1